Search

Magnetic resonance imaging (MRI) of the axilla after neoadjuvant chemotherapy is no more accurate than a clinical exam alone in predicting sentinel lymph node pathology in breast cancer patients with clinical N1 disease.

… Tuesday, December 10, 2019 Magnetic resonance imaging (MRI) of the axilla after neoadjuvant chemotherapy is no more accurate than a clinical exam alone in predicting sentinel lymph node pathology in breast cancer patients with clinical N1 (cN1) disease. Further, abnormal axillary lymph nodes on MRI should

Memorial Sloan Kettering Cancer Center (MSK) today announced the appointment of Lawrence Schwartz, MD, as MSK’s new Chair of the Department of Radiology. He will assume the role in early 2023. Dr. Schwartz is internationally recognized for his expertise in quantitative imaging, artificial intelligence in cancer imaging, and for his pioneering work in the development and validation of novel imaging biomarkers in oncology.

… Wednesday, November 16, 2022 Memorial Sloan Kettering Cancer Center (MSK) today announced the appointment of Lawrence Schwartz, MD, as MSK’s new Chair of the Department of Radiology. He will assume the role in early 2023. Dr. Schwartz is internationally recognized for his expertise in quantitative imaging

Memorial Sloan Kettering Cancer Center (MSK) has been recognized as the number two hospital for cancer care in the nation by U.S. News & World Report in its annual Best Hospitals listing. Since these prestigious rankings were established more than 30 years ago, MSK has consistently ranked among the top two cancer hospitals in the country.

… Tuesday, July 26, 2022 Memorial Sloan Kettering Cancer Center (MSK) has been recognized as the number two hospital for cancer care in the nation by  U.S. News & World Report  in its annual Best Hospitals listing. Since these prestigious rankings were established more than 30 years ago, MSK has consistently

The research was published in the New England Journal of Medicine and presented at the American Society of Hematology (ASH) Annual Meeting and Exposition.

… Tuesday, December 14, 2021 A study from Memorial Sloan Kettering Cancer Center (MSK) published today in the New England Journal of Medicine (NEJM) , found that in patients with previously untreated Diffuse Large B-Cell Lymphoma (DLBCL) Polatuzumab vedotin with Rituximab, Cyclophosphamide, Doxorubicin

Older, vulnerable patients with relapsed/refractory large B cell lymphoma should receive the same consideration for CAR T cell therapy as younger patients.

… Friday, April 3, 2020 Older, vulnerable patients with relapsed/refractory large B cell lymphoma (LBCL) should receive the same consideration for chimeric antigen receptor (CAR) T cell therapy as younger patients, according to our study published recently online and ahead of print in the journal Haematologica

The recommendation comes in the form of draft guidelines open for public comment until October 2019.

… Wednesday, August 28, 2019 Summary The FDA is recommending that men with breast cancer be included in clinical trials of breast cancer medicines. Male breast cancer is very rare — less than 1% of breast cancer cases in the U.S. occur in men. Historically, men have been excluded from breast cancer clinical

A blood-based test identifies patients in whom immunotherapy may ‘LAG.’

… Wednesday, August 25, 2021 In recent years, immune-based treatments for cancer have buoyed the hopes of doctors and patients alike. Drugs called immune checkpoint inhibitors have provided lifesaving benefits to a growing list of people with several types of cancer, including melanoma , lung cancer ,

Tomya Watt is recognized as a Notable Black Leader in today’s Crain’s New York Business special editorial feature. This piece spotlights exceptional Black individuals from various industries who have had a positive impact on New York City through their professional, communal, and philanthropic achievements.

… Monday, February 21, 2022 Tomya Watt is recognized as a Notable Black Leader in today’s Crain’s New York Business special editorial feature. This piece spotlights exceptional Black individuals from various industries who have had a positive impact on New York City through their professional, communal

Learn how MSK is improving the success of stem cell transplants from partially matched donors. This is especially important for diverse populations that can’t find full matches.

… Monday, June 10, 2024 Pedro Lara has lived the American dream. A native of El Salvador, he came to the United States as a young man more than 50 years ago and built a proud life working many jobs in Brooklyn. But when Pedro needed a  stem cell transplant after developing  non-Hodgkin lymphoma , his ancestry

Nick Kroll, Tina Fey, John Oliver, Jim Gaffigan, and other comedians team up with Memorial Sloan Kettering Cancer Center to outwit blood cancers.

… Monday, May 13, 2024 VIDEO | Memorial Sloan Kettering’s Comedy vs Cancer 2024 Video Details Comedy vs Cancer , Memorial Sloan Kettering Cancer Center’s (MSK) official comedy benefit show for blood cancer research, raised over $1.3 million on Tuesday, May 7. Over 1,000 supporters attended the one-night-only